Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Research Article

. 2021; 12(5): 889-898


Psoriasis vulgaris and new biomarkers: Tumor necrosis factor- like weak inducer of apoptosis (TWEAK) and Interleukin 17(IL17)

Amin M. Amer, Sally M. Saeed,Mai A. Samir, Sara M. Saad.

Abstract
Background and objectives:Inflammatory cytokines such as interleukin 17 (IL-17) and
tumor necrosis factor like weak inducer of apoptosis (TWEAK) were implicated in
pathogenesis of many immune mediated systemic inflammation, the current study designed
for evaluating the serum level of both marker in patients with psoriasis. Another secondary
objective was finding any possible correlation between IL-17 and TWEAK with disease
severity and duration.
Methods: 30 patients with psoriasis had enrolled in the study, and classified as regarding the
disease severity by psoriasis area and severity index (PASI) in to mild, moderate and severe.
Another 10 control subjects were involved after ethical approval. The level of IL-17,
TWEAK and CRP in serum had been measured, as well as ESR level in patients and control
group.
Results: The mean TWEAK, IL-17 levels were significantly higher in psoriasis patients than
in control subjects, P < 0.001 for both. TWEAK and IL-17 were significantly correlated with
disease severity and duration in direct way, r = 0.34 and 0.66; P = 0.03 and < 0.001, r = 0.47
and 0.39; P = 0.001 and 0.01 respectively. The performance of TWEAK and IL-17 in
predicting psoriasis were excellent, the AUC were 97% and 95% respectively.

Key words: The level of both TWEAK and IL-17 were higher in psoriases and had direct correlation with disease severity and duration.






Similar Articles

Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Journal Finder
Covid-19 Trends and Statistics
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
ScopeMed.com
Follow ScopeMed on Twitter
Online Journal Management
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.